Article
Favorable Genotypes of Type III Interferon Confer Risk of Dyslipidemia in the Population With Obesity.
Frontiers in endocrinology - 1 Jan 2022
Xu Tiantian, Peng Bo, Liu Mengmeng, Liu Qingjing, Yang Junya, Qu Minli, Liu Na, Lin Lizhen, Wu Jing
Abstract excerpt
Background: Studies have indicated that the chronic state of inflammation caused by obesity leads to dyslipidemia. However, how the polymorphisms involved in these inflammatory pathways affect the lipid metabolism in people with obesity is poorly understood. We investigated the associations of inflammation-related gene polymorphisms with dyslipidemia in individuals with obesity living in China. Methods: This...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
